• 1
    Drezner M 2002 Phosphorus homeostasis and related disorders. In: BilezikianJ, RaiszL, RodanG (eds.) Principles in Bone Biology, 2nd ed., vol. 1. Academic Press, New York, NY, USA, pp. 321338.
  • 2
    Drezner MK 2003 Hypophosphatemic rickets. Endocr Dev 6: 126155.
  • 3
    HYP Consortium 1995 A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 11: 130136.
  • 4
    Westbroek I, De Rooij KE, Nijweide PJ 2002 Osteocyte-specific monoclonal antibody MAb OB7.3 is directed against Phex protein. J Bone Miner Res 17: 845853.
  • 5
    Thompson DL, Sabbagh Y, Tenenhouse HS, Roche PC, Drezner MK, Salisbury JL, Grande JP, Poeschla EM, Kumar R 2002 Ontogeny of Phex/PHEX protein expression in mouse embryo and subcellular localization in osteoblasts. J Bone Miner Res 17: 311320.
  • 6
    Beck L, Soumounou Y, Martel J, Krishnamurthy G, Gauthier C, Goodyer CG, Tenenhouse HS 1997 Pex/PEX tissue distribution and evidence for a deletion in the 3′ region of the Pex gene in X-linked hypophosphatemic mice. J Clin Invest 99: 12001209.
  • 7
    Du L, Desbarats M, Viel J, Glorieux FH, Cawthorn C, Ecarot B 1996 cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone. Genomics 36: 2228.
  • 8
    Guo R, Quarles LD 1997 Cloning and sequencing of human PEX from a bone cDNA library: Evidence for its developmental stage-specific regulation in osteoblasts. J Bone Miner Res 12: 10091017.
  • 9
    Ruchon AF, Marcinkiewicz M, Siegfried G, Tenenhouse HS, DesGroseillers L, Crine P, Boileau G 1998 Pex mRNA is localized in developing mouse osteoblasts and odontoblasts. J Histochem Cytochem 46: 459468.
  • 10
    Strom TM, Francis F, Lorenz B, Boddrich A, Econs MJ, Lehrach H, Meitinger T 1997 Pex gene deletions in Gy and Hyp mice provide mouse models for X-linked hypophosphatemia. Hum Mol Genet 6: 165171.
  • 11
    Carpinelli MR, Wicks IP, Sims NA, O'Donnell K, Hanzinikolas K, Burt R, Foote SJ, Bahlo M, Alexander WS, Hilton DJ 2002 An ethyl-nitrosourea-induced point mutation in phex causes exon skipping, x-linked hypophosphatemia, and rickets. Am J Pathol 161: 19251933.
  • 12
    Lorenz-Depiereux B, Guido VE, Johnson KR, Zheng QY, Gagnon LH, Bauschatz JD, Davisson MT, Washburn LL, Donahue LR, Strom TM, Eicher EM 2004 New intragenic deletions in the Phex gene clarify X-linked hypophosphatemia-related abnormalities in mice. Mamm Genome 15: 151161.
  • 13
    Eicher E, Southard J, Scriver C, Glorieux F 1976 Hypophosphataemia: Mouse model for human familial hypophsphataemic (vitamin D-resistant) rickets. Proc Natl Acad Sci USA 73: 46674671.
  • 14
    Tenenhouse HS 1999 X-linked hypophosphataemia: A homologous disorder in humans and mice. Nephrol Dial Transplant 14: 333341.
  • 15
    Yamamoto T, Ecarot B, Glorieux F 1992 Abnormal response of osteoblasts from Hyp mice to 1,25-dihydroxyvitamin D3. Bone 13: 209215.
  • 16
    Tenenhouse H 1984 Investigation of the mechanism for abnormal renal 25-hydroxyvitamin D3-1-hydroxylase activity in the X-linked Hyp mouse. Endocrinology 115: 634639.
  • 17
    Nesbitt T, Coffman T, Griffith R, Drezner M 1992 Crosstransplantation of kidneys in normal and Hyp mice. J Clin Invest 89: 14531459.
  • 18
    Meyer R Jr, Meyer M, Gray R 1989 Parabiosis suggests a humoral factor is involved in X-linked hypophosphataemia in mice. J Bone Miner Res 4: 493500.
  • 19
    Meyer R Jr, Tenenhouse H, Meyer M, Klugerman A 1989 The renal phosphate transport defect in normal mice parabiosed to X-linked hypophosphataemic mice persists after parathyroidectomy. J Bone Miner Res 4: 523532.
  • 20
    Meyer RA Jr, Henley CM, Meyer MH, Morgan PL, McDonald AG, Mills C, Price DK 1998 Partial deletion of both the spermine synthase gene and the Pex gene in the X-linked hypophosphatemic, gyro (Gy) mouse. Genomics 48: 289295.
  • 21
    Ecarot-Charrier B, Glorieux F, Travers R, Desbarats M, Bouchard F, Hinek A 1988 Defective bone formation by transplanted Hyp mouse bone cells into normal mice. Endocrinology 123: 768773.
  • 22
    Xiao ZS, Crenshaw M, Guo R, Nesbitt T, Drezner MK, Quarles LD 1998 Intrinsic mineralization defect in hyp mouse osteoblasts. Am J Physiol Endocrinol Metab 38: 700708.
  • 23
    Tenenhouse HS, Sabbagh Y 2002 Novel phosphate-regulating genes in the pathogenesis of renal phosphate wasting disorders. Pflugers Arch 444: 317326.
  • 24
    Econs MJ 1999 New insights into the pathogenesis of inherited phosphate wasting disorders. Bone 25: 131135.
  • 25
    Econs MJ, McEnery PT, Lennon F, Speer MC 1997 Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13. J Clin Invest 100: 26532657.
  • 26
    ADHR Consortium 2000 Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. The ADHR Consortium. Nat Genet 26: 345348.
  • 27
    Bowe AE, Finnegan R, Jan de Beur SM, Cho J, Levine MA, Kumar R, Schiavi SC 2001 FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate. Biochem Biophys Res Commun 284: 977981.
  • 28
    Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T 2001 Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98: 65006505.
  • 29
    Shimada T, Urakawa I, Yamazaki Y, Hasegawa H, Hino R, Yoneya T, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T 2004 FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa. Biochem Biophys Res Commun 314: 409414.
  • 30
    Larsson T, Marsell R, Schipani E, Ohlsson C, Ljunggren O, Tenenhouse HS, Juppner H, Jonsson KB 2004 Transgenic mice expressing Fibroblast Growth Factor 23 under the control of the {alpha}1(I) collagen promoter exhibit growth retardation, osteomalacia and disturbed phosphate homeostasis. Endocrinology 145: 30873094.
  • 31
    Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, Takeuchi Y, Fujita T, Nakahara K, Yamashita T, Fukumoto S 2002 Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 87: 49574960.
  • 32
    Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Juppner H 2003 Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348: 16561663.
  • 33
    Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, Waguespack S, Gupta A, Hannon T, Econs MJ, Bianco P, Gehron Robey P 2003 FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 112: 683692.
  • 34
    Liu S, Guo R, Simpson LG, Xiao ZS, Burnham CE, Quarles LD 2003 Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEX. J Biol Chem 278: 3741937426.
  • 35
    Lipman ML, Panda D, Bennett HP, Henderson JE, Shane E, Shen Y, Goltzman D, Karaplis AC 1998 Cloning of human PEX cDNA. Expression, subcellular localization, and endopeptidase activity. J Biol Chem 273: 1372913737.
  • 36
    Boileau G, Tenenhouse HS, Desgroseillers L, Crine P 2001 Characterization of PHEX endopeptidase catalytic activity: Identification of parathyroid-hormone-related peptide107–139 as a substrate and osteocalcin, PPi and phosphate as inhibitors. Biochem J 355: 707713.
  • 37
    Bai X, Miao D, Panda D, Grady S, McKee MD, Goltzman D, Karaplis AC 2002 Partial rescue of the Hyp phenotype by osteoblast-targeted PHEX (phosphate-regulating gene with homologies to endopeptidases on the X chromosome) expression. Mol Endocrinol 16: 29132925.
  • 38
    Liu S, Guo R, Tu Q, Quarles LD 2002 Overexpression of Phex in osteoblasts fails to rescue the Hyp mouse phenotype. J Biol Chem 277: 36863697.
  • 39
    Quarles LD 2003 FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am J Physiol Endocrinol Metab 285: E1E9.
  • 40
    Berndt T, Craig TA, Bowe AE, Vassiliadis J, Reczek D, Finnegan R, Jan De Beur SM, Schiavi SC, Kumar R 2003 Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent. J Clin Invest 112: 785794.
  • 41
    Schiavi SC, Moe OW 2002 Phosphatonins: A new class of phosphate-regulating proteins. Curr Opin Nephrol Hypertens 11: 423430.
  • 42
    Rowe PS, Kumagai Y, Gutierrez G, Garrett IR, Blacher R, Rosen D, Cundy J, Navvab S, Chen D, Drezner MK, Quarles LD, Mundy GR 2004 MEPE has the properties of an osteoblastic phosphatonin and minhibin. Bone 34: 303319.
  • 43
    Dymecki S 1996 A modular set of Flp, FRT and lacZ fusion vectors for manipulating genes by site-specific recombination. Gene 171: 197201.
  • 44
    Meyer MH, Meyer RA Jr, Gray RW, Irwin RL 1985 Picric acid methods greatly overestimate serum creatinine in mice: More accurate results with high-performance liquid chromatography. Anal Biochem 144: 285290.
  • 45
    Brewer AJ, Canaff L, Hendy GN, Tenenhouse HS 2004 Differential regulation of PHEX expression in bone and parathyroid gland by chronic renal insufficiency and 1,25-dihydroxyvitamin D3. Am J Physiol Renal Physiol 286: F739F748.
  • 46
    Ruchon AF, Tenenhouse HS, Marcinkiewicz M, Siegfried G, Aubin JE, DesGroseillers L, Crine P, Boileau G 2000 Developmental expression and tissue distribution of Phex protein: Effect of the Hyp mutation and relationship to bone markers. J Bone Miner Res 15: 14401450.
  • 47
    Erben R 1997 Embedding of bone samples in methylmethacrylate: An improved method suitable for bone histomorphometry, histochemistry, and immunohistochemistry. J Histochem Cytochem 45: 307313.
  • 48
    Schenk R, Olah A, Herrmann W 1984 Preparation of calcified tissues for light microscopy. In: DicksonG (ed.) Methods of Calcified Tissue Preparation. Elsevier, Amsterdam, The Netherlands, pp. 156.
  • 49
    Kozak M 1996 Interpreting cDNA sequences: Some insights from studies on translation. Mamm Genome 7: 563574.
  • 50
    Liu S, Guo R, Quarles LD 2001 Cloning and characterization of the proximal murine Phex promoter. Endocrinology 142: 39873995.
  • 51
    Winters RW, Graham JB, Williams TF, Mc FV, Burnett CH 1957 A genetic study of familial hypophosphatemia and vitamin D resistant rickets. Trans Assoc Am Physicians 70: 234242.
  • 52
    Meyer RA Jr, Meyer MH, Gray RW, Bruns ME 1987 Evidence that low plasma 1,25-dihydroxyvitamin D causes intestinal malabsorption of calcium and phosphate in juvenile X-linked hypophosphatemic mice. J Bone Miner Res 2: 6782.
  • 53
    Meyer MH, Meyer RA Jr 1988 Increased intestinal absorption of calcium in young and adult X-linked hypophosphatemic mice after the administration of 1,25-dihydroxyvitamin D3. J Bone Miner Res 3: 151157.
  • 54
    Bai X, Miao D, Li J, Goltzman D, Karaplis A 2003 Early lethality in Hyp mice with targeted deletion of the PTH gene. J Bone Miner Res 18: S2: 1080.
  • 55
    Bai X, Miao D, Li J, Goltzman D, Karaplis AC 2004 Transgenic mice overexpressing human fibroblast growth factor 23(R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders. Endocrinology 145: 52695279.